Provided by Tiger Trade Technology Pte. Ltd.

BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD

0.4622
-0.0615-11.74%
Volume:100.81K
Turnover:48.57K
Market Cap:475.65K
PE:-0.08
High:0.5200
Open:0.5200
Low:0.4622
Close:0.5237
52wk High:59.40
52wk Low:0.4622
Shares:1.03M
Float Shares:943.50K
Volume Ratio:1.66
T/O Rate:10.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.6940
EPS(LYR):-78.3088
ROE:-42.00%
ROA:-40.11%
PB:0.04
PE(LYR):-0.01

Loading ...

Biodexa recruits 87 of 168 subjects in Serenta Phase 3 eRapa polyposis trial

TIPRANKS
·
Aug 19

Biodexa Tops 50% Enrollment in Serenta Phase 3 FAP Trial of eRapa

Reuters
·
Aug 19

European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading

MT Newswires Live
·
Aug 14

European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading

MT Newswires Live
·
Aug 06

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live
·
Aug 03

Biodexa Pharmaceuticals Held General Meeting, Shareholders Passed Four Resolutions

Reuters
·
Jul 30

Result of General Meeting

GlobeNewswire
·
Jul 30

European Equities Traded in US as ADRs Ease in Wednesday Trading

MT Newswires Live
·
Jul 29

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires Live
·
Jul 22

European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading

MT Newswires Live
·
Jul 20

Biodexa Seeks Shareholder Approval to Adopt New Articles of Association for E Deferred Shares

Reuters
·
Jul 10

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading

MT Newswires Live
·
Jul 02

European Equities Traded in the US as American Depositary Receipts Fall Sharply in Wednesday Trading

MT Newswires Live
·
Jul 01

Biodexa Amends June 6-K to File Legal Opinion Exhibit

Reuters
·
Jul 01

Biodexa Pharmaceuticals Holds Annual General Meeting

Reuters
·
Jul 01

Result of Annual General Meeting

GlobeNewswire
·
Jul 01

Biodexa Prices $1 Million Private Placement of Pre-funded Warrants at $2.85 Per ADS

Reuters
·
Jun 30

Biodexa Pharmaceuticals announces pricing of $3.5M registered offering

TIPRANKS
·
Jun 30

Biodexa to Issue Series M, N and O Warrants with $2.85 Exercise Price Pending Shareholder Approval

Reuters
·
Jun 30

European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading

MT Newswires Live
·
Jun 29